Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 46Triple Negative Breast Neoplasms 10Colorectal Neoplasms 6Prostatic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Uterine Cervical Neoplasms 3Ovarian Neoplasms 3Neoplasm Metastasis 3Carcinoma, Renal Cell 3Stomach Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Melanoma 2Lung Neoplasms 2Endometrial Neoplasms 2Colonic Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Vulvar Neoplasms 1Vaginitis 1Uterine Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Osteosarcoma 1Multiple Myeloma 1Margins of Excision 1Lymphedema 1Liver Neoplasms 1Hypertension 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Dihydropyrimidine Dehydrogenase Deficiency × Breast × Clear all
NCT04541381 2026-05-07

The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care

University of Chicago

Phase NA Suspended
860 enrolled
BreastGastrointestinalHead & Neck

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Dihydropyrimidine Dehydrogenase Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡